Identification |
Name: | Butanamide,N-[[(6S,7R,9R,14aS,15R)-7-cyano-1,5,6,7,9,10,13,14,14a,15-decahydro-2,11-dimethoxy-3,12,16-trimethyl-1,4,10,13-tetraoxo-6,15-imino-4H-isoquino[3,2-b][3]benzazocin-9-yl]methyl]-2-oxo- |
Synonyms: | Butanamide,N-[(7-cyano-1,5,6,7,9,10,13,14,14a,15-decahydro-2,11-dimethoxy-3,12,16-trimethyl-1,4,10,13-tetraoxo-6,15-imino-4H-isoquino[3,2-b][3]benzazocin-9-yl)methyl]-2-oxo-,[6S-(6a,7a,9b,14aa,15a)]-; 6,15-Imino-4H-isoquino[3,2-b][3]benzazocine,butanamide deriv.; Saframycin Ad 1 |
CAS: | 107140-33-0 |
Molecular Formula: | C30H32 N4 O8 |
Molecular Weight: | 0 |
InChI: | InChI=1/C30H32N4O8/c1-7-20(35)30(40)32-11-19-21-14(24(36)12(2)28(41-5)26(21)38)9-17-23-22-15(25(37)13(3)29(42-6)27(22)39)8-16(33(23)4)18(10-31)34(17)19/h16-19,23H,7-9,11H2,1-6H3,(H,32,40) |
Molecular Structure: |
|
Properties |
Flash Point: | °C |
Boiling Point: | °Cat760mmHg |
Density: | 1.41g/cm3 |
Refractive index: | 1.626 |
Flash Point: | °C |
Safety Data |
|
|